Work

Positron-Emission Tomographic Imaging of a Fluorine 18–Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient–Derived Xenografts

Year: 2019

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.05.032

Authors: James Laird, Benjamin H. Lok, Brandon Carney, Susanne Kossatz, Elisa de Stanchina, Thomas Reiner, John T. Poirier, Charles M. Rudin

Institutions: Memorial Sloan Kettering Cancer Center, New York University, The Graduate Center, CUNY, City University of New York, Hunter College, Cornell University, Weill Cornell Medicine

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Conquer Cancer Foundation, Lung Cancer Research Foundation, National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: G1125781002, G1166570371, G3117500281, G4651258030, G4680584537, G876475942, G9000079197, Cancer Center Support Grant, Clinical and Translational Science Center

OpenAlex ID: W2952695950

FWCI: 0.997

Cites: 41

Cited by: 20

Related to: 10